RPTX(Delisted)
Repare·NASDAQ
--
--(--)
6.29 / 10
Outperform
Fundamental analysis of Repare Therapeutics shows a positive stance with a 6.3/10 score. Key strengths include PB-ROE (-0.4565) and Asset-MV (-0.5100) placing the stock in high-performing quartiles, historically yielding 12.56% and 15.86% monthly returns, respectively. However, caution is advised for Interest coverage ratio (-165.03) and Revenue-MV (-0.2806) due to suboptimal values. Inventory turnover (47.95) and fixed-assets efficiency (5.63) are reasonable, but cash-to-market value (-0.3577) is low. Management should address leverage and revenue scaling to improve fundamentals.
Analysis Checks(6/10)
Revenue-MV
Value-0.28
Score1/3
Weight10.18%
1M Return5.74%
Value-0.28
Score1/3
Weight10.18%
1M Return5.74%
Gross profit margin (%)
Value100.00
Score1/3
Weight0.22%
1M Return0.17%
Value100.00
Score1/3
Weight0.22%
1M Return0.17%
Income tax / Total profit (%)
Value-1.78
Score1/3
Weight0.45%
1M Return0.31%
Value-1.78
Score1/3
Weight0.45%
1M Return0.31%
Fixed assets turnover ratio
Value5.63
Score3/3
Weight2.14%
1M Return1.53%
Value5.63
Score3/3
Weight2.14%
1M Return1.53%
Asset-MV
Value-0.51
Score3/3
Weight38.63%
1M Return15.86%
Value-0.51
Score3/3
Weight38.63%
1M Return15.86%
Inventory turnover ratio
Value47.95
Score3/3
Weight9.56%
1M Return6.07%
Value47.95
Score3/3
Weight9.56%
1M Return6.07%
PB-ROE
Value-0.46
Score3/3
Weight24.86%
1M Return12.56%
Value-0.46
Score3/3
Weight24.86%
1M Return12.56%
Current assets turnover ratio
Value0.08
Score2/3
Weight2.44%
1M Return1.69%
Value0.08
Score2/3
Weight2.44%
1M Return1.69%
Interest coverage ratio (EBIT / Interest expense) (%)
Value-165.03
Score1/3
Weight-1.99%
1M Return-1.39%
Value-165.03
Score1/3
Weight-1.99%
1M Return-1.39%
Cash-MV
Value-0.36
Score2/3
Weight13.50%
1M Return7.38%
Value-0.36
Score2/3
Weight13.50%
1M Return7.38%
Revenue-MV
Value-0.28
Score1/3
Weight10.18%
1M Return5.74%
Value-0.28
Score1/3
Weight10.18%
1M Return5.74%
Inventory turnover ratio
Value47.95
Score3/3
Weight9.56%
1M Return6.07%
Value47.95
Score3/3
Weight9.56%
1M Return6.07%
Gross profit margin (%)
Value100.00
Score1/3
Weight0.22%
1M Return0.17%
Value100.00
Score1/3
Weight0.22%
1M Return0.17%
PB-ROE
Value-0.46
Score3/3
Weight24.86%
1M Return12.56%
Value-0.46
Score3/3
Weight24.86%
1M Return12.56%
Income tax / Total profit (%)
Value-1.78
Score1/3
Weight0.45%
1M Return0.31%
Value-1.78
Score1/3
Weight0.45%
1M Return0.31%
Current assets turnover ratio
Value0.08
Score2/3
Weight2.44%
1M Return1.69%
Value0.08
Score2/3
Weight2.44%
1M Return1.69%
Fixed assets turnover ratio
Value5.63
Score3/3
Weight2.14%
1M Return1.53%
Value5.63
Score3/3
Weight2.14%
1M Return1.53%
Interest coverage ratio (EBIT / Interest expense) (%)
Value-165.03
Score1/3
Weight-1.99%
1M Return-1.39%
Value-165.03
Score1/3
Weight-1.99%
1M Return-1.39%
Asset-MV
Value-0.51
Score3/3
Weight38.63%
1M Return15.86%
Value-0.51
Score3/3
Weight38.63%
1M Return15.86%
Cash-MV
Value-0.36
Score2/3
Weight13.50%
1M Return7.38%
Value-0.36
Score2/3
Weight13.50%
1M Return7.38%
Is RPTX undervalued or overvalued?
- RPTX scores 6.29/10 on fundamentals and holds a Discounted valuation at present. Backed by its -32.70% ROE, -608.26% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and 14.57% earnings growth, these metrics solidify its Outperform investment rating.
